Dr. Sexton, a Board-Certified Orthopaedic surgeon, Fellow of the Arthroscopy Association of North America, and Army Veteran, joins one of the fastest-growing orthopaedic practices in Florida
…
Dr. Sexton, a Board-Certified Orthopaedic surgeon, Fellow of the Arthroscopy Association of North America, and Army Veteran, joins one of the fastest-growing orthopaedic practices in Florida
…
New Logo Captures Company’s Growth, Stability and Heritage
DULUTH, Ga. – January 9, 2023 – (Newswire.com)
Atlanta Dental announces the unveiling of a new logo and brand identity that supports the company’s continued forward motion and digital transformation. Atlanta Dental is one of the nation’s leading dental product and technology distributors supporting dentists as they deliver excellent clinical care, while also helping them build a fundamentally strong business. Founded in 1868, Atlanta Dental has grown into a diverse dental distributor with a rich heritage of service to the dental community.
The new logo is designed to convey four core tenets of Atlanta Dental’s long-term success: respect, trust, accountability and innovation. “Our new brand and logo express our commitment to meet our customers where they are, both on and offline and at their greatest point of need. This is consistent with the steps we have taken to innovate our digital strategy while continuing to deliver the highest quality products, technical service and the full support our customers expect,” said Gary Kirkus, CEO of Atlanta Dental.
While the new logo portrays graceful stability, it also serves as a strong anchor for Atlanta Dental’s sub-brands.
“The dental profession and the industry that supports it are continually in a state of transformation,” said Tom Richardson, President of Atlanta Dental. “Our new logo represents our desire to contribute to our customers’ success as their needs evolve, as well as our partners and our employees who meet and exceed customer expectations on a daily basis.”
With its new corporate brand, Atlanta Dental is steadfast in its commitment to the advancement of dentistry and investment in its future.
Atlanta Dental is independent, privately held, and employee-owned.
Learn more by visiting AtlantaDental.com.
Contact Information:
Tom Richardson
President
[email protected]
678-584-4830
Press Release Service
by
Newswire.com
Original Source:
Atlanta Dental Unveils New Logo and Brand Identity
Roma are desperate for points as they travel to Helsinki to face HJK. Anything other than a win
The device’s ease of use permits players to wear sam® for long periods discreetly, allowing athletes to attend class while maintaining 100% treatment compliance during recovery.
AUSTIN, Texas – January 9, 2023 – (Newswire.com)
A Texas collegiate football program is taking advantage of sustained acoustic medicine (sam®), a low-intensity, long-duration ultrasound treatment developed by ZetrOZ Systems. Injured athletes are utilizing the device while in class, allowing them to recover from injury and get the full benefit of the recommended one-hour treatment time without sacrificing attendance.
A representative from the ZetrOZ Systems sports medicine team visited the organization to discuss the sam® device. One account involved a wide receiver at the college who suffered from plantar fasciitis. His trainer put him on a treatment using the sam®x1 wireless unit, allowing him to attend team lunches and class while undergoing the full hour of treatment time.
An innovation in wearable health technology, sam® is a wearable, mechanobiological device that delivers high-frequency sound waves to the affected area, helping to increase blood flow while reducing inflammation and swelling. The increased oxygenated hemoglobin at the injury site removes cytokine enzymes and cellular waste and can be particularly useful for treating injuries such as strains, sprains, and muscle tears, as well as chronic conditions such as tendonitis and bursitis.
In addition to its anti-inflammatory effects, long-duration ultrasound therapy has also been found to reduce pain, improve mobility, and accelerate tissue repair. It is generally considered a safe and non-invasive treatment option with few side effects.
Backed by over 30 clinical studies, the sam® device was developed from research funded by the National Institute of Health and the U.S. Department of Defense to provide effective soft tissue healing and reduce the use of narcotics and invasive treatments.
To learn more, visit zetroz.com.
About ZetrOZ Systems
ZetrOZ Systems is leading healing innovations in sports medicine and developing wearable bioelectronic devices for the delivery of sustained acoustic medicine (sam®). Researched and funded by the federal government, ZetrOZ is built on proprietary medical technology of +46 patents and is the exclusive manufacturer and developer of sam®, a product line designed for the treatment of acute and chronic musculoskeletal conditions. To learn more, visit zetroz.com.
Contact Information:
Buse Kayar
[email protected]
Press Release Service
by
Newswire.com
Original Source:
Sustained Acoustic Medicine Enables Student-Athletes to Recover in the Classroom While Meeting Their Academic Obligations
SurgiVance, a leading innovator in developing AI-driven, direct-to-digital confocal pathology, announced today that Michael Li, PhD has been appointed Chief Executive Officer.
…
New Value-Based Care Company Addresses Health Disparities Among Seniors in Rural America
MYRTLE BEACH, S.C. – …
Gwen, her family and the creators of this monumental training manikin will be available for media interviews Jan. 23, 2023, 9:30am-11:30am at the Orange County Convention Center. Press passes must be secured by Jan. 17 for the Jan. 23, 2023, event.
ORLANDO, Fla. – January 9, 2023 – (Newswire.com)
Lifecast Body Simulation Global (Echo Healthcare), a leader in hyper-realistic training manikins, will debut the world’s first Child with Down Syndrome training manikin Jan. 23 at the International Meeting on Simulation in Healthcare (IMSH) conference in Orlando, Florida. This realistic medical manikin was formed from a real-life 3D body scan of a seven-year-old girl with Down syndrome named Gwen and will be available to healthcare education facilities around the world to facilitate specialty and inclusive training in managing patients with Down syndrome.
Gwen was created by Lifecast Body Simulation and the University of Greenwich, which received support from the Down Syndrome Association. This debut is monumental in the world of medical education and is guaranteed to make waves at the largest international medical simulation conference held in the U.S. There is no other medical training manikin available that accurately represents a child with Down syndrome, making Gwen the first in the world. The Gwen manikin allows healthcare providers to become accurately trained on how to treat a patient with Down Syndrome. Given variations in their airway, stature and anatomy, without proper training, additional harm can be unintentionally done by medical providers.
Down syndrome is a genetic disorder caused when abnormal cell division results in extra genetic material from chromosome 21. While varied amongst patients, a few common physical traits of Down syndrome are low muscle tone, a difficult airway for intubation, smaller stature, toe gapping, almond-shaped eyes, a single deep crease across the center of the palm, smaller hands and feet – all of which are accurately represented in the Gwen manikin.
“We are thrilled to offer the world’s first medical manikin focusing on Down syndrome. Children with Down Syndrome are truly amazing but also very complex to treat from a medical standpoint. Our goal with the Gwen manikin is to ensure every healthcare provider is properly trained for when they do encounter a child with Down Syndrome in their clinical practice so we can mitigate any risk and ultimately improve patient safety,” says Kevin King, CEO of Lifecast Body Simulation Global.
The Gwen manikin, along with the real-life Gwen and her family, will be at the International Meeting on Simulation in Healthcare (IMSH) to meet with the local media on Jan. 23, 2023, from 9:30am – 11:30am in Echo Healthcare Booth #111. Press passes are required to enter the conference exhibit area to interview Gwen and her family, the creators of the Gwen manikin and healthcare providers. Please contact Nicole Sherk prior to Jan. 17 to secure your press pass.
Contact Information:
Nicole Sherk
Marketing Manager
[email protected]
9412330854
Press Release Service
by
Newswire.com
•• Complete epithelial recovery was achieved by 67% of subjects receiving NEXAGON, as opposed to 27% receiving Vehicle alone
•• NEXAGON was well-tolerated demonstrating a safety profile similar to vehicle
•• Amber plan…